Your Messages Inbox (0) 
Your Unread Messages
See AllMost Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus
Current Medical Research and Opinion, 11/06/09
Seino Y et al. – Weekly and biweekly albiglutide improved glycemic control and were well–tolerated in Japanese subjects with type 2 diabetes mellitus.
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Good clinical endpoints with denosumab in osteoporosis and cancer
Expert Opinion in Pharmacotherapy, 11/23/09
Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophy
Therapeutic Advances in Neurological Disorders, 11/23/09
Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US
Current Medical Research and Opinion, 11/20/09
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Clinical Cancer Research, 11/20/09
Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients
Transplantation Proceedings, 11/20/09
Physiologically-Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin
Drug Metabolism and Disposition, 11/20/09
Sponsor
Article Search
Sponsor